Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04068220
Other study ID # 20190533 - 01H
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 2, 2020
Est. completion date December 31, 2021

Study information

Verified date September 2020
Source Ottawa Hospital Research Institute
Contact Ioana D Moldovan, MD MSc
Phone 613-798-5555
Email imoldovan@ohri.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Skull base surgeries performed in areas involving the visual pathway are associated with varying levels of postoperative visual dysfunction. The goal of intraoperative FVEP monitoring is to detect and prevent intraoperative visual pathway injury.


Description:

Skull base surgeries performed in areas involving the visual pathway are associated with varying levels of postoperative visual dysfunction. For instance, surgical resection of suprasellar meningiomas has been shown to worsen visual function in 14 - 28% of patients and surgical resection of craniopharyngiomas worsen visual function in 3 - 11.5% of patients. Manipulation of the optic nerve and interference with the microvasculature during surgical dissection is thought to be responsible for the visual loss.

Through intraoperative monitoring and prompt identification of flash visual evoked potentials (FVEPs) deterioration, corrective surgical measures could be undertaken to improve or stabilize postoperative visual dysfunction. Furthermore, intraoperative FVEPs monitoring may influence surgical decision-making thus contributing to predict and prevent postoperative visual dysfunction as well as allowing more total resection of a tumour when the monitoring is stable.

This study's aim is to determine if intraoperative continuous FVEPs monitoring can predict and prevent or minimize possible visual pathway injury that may appear during minimally invasive endoscopic skull base surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 31, 2021
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult population (18 years and older), admitted to The Ottawa Hospital (TOH)-Civic Campus for a chiasmal or pre-chiasmal lesion, undergoing first time minimally invasive endoscopic skull base surgery

- Patient able to personally sign and date the informed consent document

- Patients will be selected based on the surgeon's determination that:

1. The visual system will be at risk of iatrogenic injury

2. The intraoperative FVEPs monitoring could rapidly detect this injury AND

3. Corrective measures could be taken during surgery to reverse it.

Exclusion Criteria:

- patients having a pre-existent retinal disease, cardiac pacemaker

- contraindication for total intravenous anaesthesia (TIVA)

- unable to complete required pre and post-operative visual assessment or unable to complete their post-operative follow-up visits at TOH-Civic Campus

- anticipated goggle movement related to reflection of the frontal skin flap

- preoperative visual deficits (e.g., profound deficits in visual acuity or dense visual field loss)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
intraoperative FVEPs monitoring
During the surgery, a pair of goggles (similar to the swimming goggles) will be placed on patient's closed eyes. The goggles equipped with red LEDs will apply no pressure or minimal pressure on patient's closed eyes. Patient's left eye then right eye will be stimulated with flashing red light emitted by the goggles. Two subdermal needle electrodes will be placed under the skin behind patient's ears, and one subdermal needle electrode will be placed under the skin above the bridge of patient's nose. The two electrodes placed behind patient's ears, will record intraoperative flash visual evoked potentials (FVEPs) resulted from red light stimulation of patient's visual pathway through the eyes and the electrode above the bridge of the nose will record, at the same time, the activity of each eye's retina.

Locations

Country Name City State
Canada The Ottawa Hospital - Civic Campus Ottawa Ontario

Sponsors (2)

Lead Sponsor Collaborator
Fahad AlKherayf Ottawa Hospital Research Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Examine the feasibility of detecting iatrogenic visual pathway injury by using intraoperative monitoring of continuous FVEPs in minimally invasive endoscopic skull base surgery. This pilot study will evaluate the number of enrolled patients with stable and reliable FVEPs with ERGs, the number of enrolled patients with more than 50% decrease in intraoperative FVEPs N1-P1 amplitude (compared to baseline value) and the number of patients with permanent postoperative visual deficit. In addition, we will use demographic data for descriptive analysis, and obtain preliminary data for power analysis and information on subject recruitment before starting the large clinical trial. 1 year
Secondary Determine sensitivity and specificity as well as positive and negative predictive value of intraoperative monitoring of continuous FVEPs in minimally invasive endoscopic skull base surgery. Evaluation of proportions (sensitivity and specificity) and performances (positive and negative predictive values) 1 year
Secondary Report the adverse events of intraoperative monitoring continuous FVEPs Determine the number and percentage of each identified adverse event of intraoperative continuous FVEPs monitoring. 1 year

External Links